US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CALCIMEDICA

1.50

-0.0250-1.64%

Post-market: 1.500.00000.00%18:27 EDT

Volume:20.39K

Turnover:30.75K

Market Cap:20.22M

PE:-1.23

High:1.53

Open:1.49

Low:1.48

Close:1.53

Loading ...

Overview Company News Filings

CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference

CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

BRIEF-CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors

CalciMedica Announces Board Changes and New Appointment

CalciMedica Announces Appointment of DR. Alan Glicklich to Board of Directors

THOMSON REUTERS

Press Release: CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors

CalciMedica Announces Presentations at Upcoming Medical Meetings

CalciMedica Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

CalciMedica’s Financial Strength and Clinical Advancements Lead to Buy Rating

CalciMedica Inc reports results for the quarter ended September 30 - Earnings Summary

BRIEF-Calcimedica Reports Third Quarter 2024 Financial Results And Provides Clinical & Corporate Updates

CalciMedica Q3 2024 GAAP EPS $(0.50), Inline, Proforma Cash, Cash Equivalents And Short-term Investments Of Approximately $23.7M, Which Is Expected To Fund Current Operations Into The First Half Of 2026

CalciMedica Inc: Cash Position Is Expected to Fund Current Operations Into First Half of 2026

THOMSON REUTERS

CalciMedica Q3 Basic EPS USD -0.5

THOMSON REUTERS

CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

PK AirFinance Arranges and Funds Scaled Portfolio Facility for CALC’s Sidecar Platform (CAG)

CalciMedica name Stephen Bardin as CFO

BRIEF-CalciMedica Strengthens Leadership Team With Appointment Of Stephen Bardin As Chief Financial Officer

CalciMedica Inc - Appoints Stephen Bardin as CFO

THOMSON REUTERS

CalciMedica Strengthens Leadership Team With Appointment of Stephen Bardin as Chief Financial Officer

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CALC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CALC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CALC\",,,,,undefined,":{"symbol":"CALC","market":"US","secType":"STK","nameCN":"CALCIMEDICA","latestPrice":1.5,"timestamp":1745611200000,"preClose":1.525,"halted":0,"volume":20392,"hourTrading":{"tag":"盘后","latestPrice":1.5,"preClose":1.5,"latestTime":"18:27 EDT","volume":62,"amount":95.78,"timestamp":1745620053916},"delay":0,"floatShares":5397734,"shares":13481917,"eps":-1.21822,"marketStatus":"Market Closed","change":-0.025,"latestTime":"04-25 16:00:00 EDT","open":1.485,"high":1.53,"low":1.475,"amount":30753.0487696,"amplitude":0.036066,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.21822,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":1.525,"postHourTrading":{"tag":"盘后","latestPrice":1.5,"preClose":1.5,"latestTime":"18:27 EDT","volume":62,"amount":95.78,"timestamp":1745620053916},"volumeRatio":0.8766378955072321},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CALC\",,,,,undefined,":{"symbol":"CALC","floatShares":5397734,"roa":"-94.61%","roe":"-121.42%","lyrEps":-1.21822,"volumeRatio":0.8766378955072321,"shares":13481917,"dividePrice":0,"high":1.53,"amplitude":0.036066,"preClose":1.525,"low":1.475,"week52Low":1.43,"pbRate":"1.40","week52High":6.265,"institutionHeld":0,"latestPrice":1.5,"eps":-1.21822,"divideRate":0,"volume":20392,"delay":0,"ttmEps":-1.21822,"open":1.485,"prevYearClose":3.54,"prevWeekClose":1.55,"prevMonthClose":1.91,"prevQuarterClose":1.91,"fiveDayClose":1.55,"twentyDayClose":2.07,"sixtyDayClose":2.63},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CALC\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2512064881","title":"CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2512064881","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512064881?lang=en_us&edition=fundamental","pubTime":"2025-02-19 20:00","pubTimestamp":1739966400,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., Feb. 19, 2025 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced a plenary presentation at the 30th International Acute Kidney Injury and Continuous Renal Replacement Therapy Conference  being held March 3-6, 2025 in San Diego, CA.Session Title: Plenary 2: Bench to Bedside: Translating Discoveries to Clinical Care. Session Date and Time: Monday, March 3, 10:35-10:55 a.m. PT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-announces-upcoming-plenary-presentation-120000500.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-announces-upcoming-plenary-presentation-120000500.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","AP","BK4006","CALC"],"gpt_icon":0},{"id":"2508178010","title":"CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2508178010","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508178010?lang=en_us&edition=fundamental","pubTime":"2025-02-04 05:05","pubTimestamp":1738616700,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., Feb. 3, 2025 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that Rachel Leheny, Ph.D., Chief Executive Officer, will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on Wednesday, February 12, 2025, at 8:00 a.m. ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-participate-oppenheimer-35th-annual-210500130.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-participate-oppenheimer-35th-annual-210500130.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","AP","OPY","CALC","BK4137","BK4006","HCSG","BK4127"],"gpt_icon":0},{"id":"2503852257","title":"BRIEF-CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2503852257","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503852257?lang=en_us&edition=fundamental","pubTime":"2025-01-14 20:40","pubTimestamp":1736858409,"startTime":"0","endTime":"0","summary":"BRIEF-CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of DirectorsJan 14 (Reuters) - CalciMedica Inc CALC.O:CALCIMEDICA ANNOUNCES APPOINTMENT OF DR. ALAN GLICKLICH TO BOARD OF DIRECTORSSource text: ID:nPn4YWh6laFurther company coverage: CALC.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nTUA7NR9WH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2503524718","title":"CalciMedica Announces Board Changes and New Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2503524718","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503524718?lang=en_us&edition=fundamental","pubTime":"2025-01-14 20:30","pubTimestamp":1736857832,"startTime":"0","endTime":"0","summary":"CalciMedica ( ($CALC) ) has issued an announcement. On January 10, 2025, Eric Bjerkholt resigned from the board of directors and audit committee of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/calcimedica-announces-board-changes-and-new-appointment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/calcimedica-announces-board-changes-and-new-appointment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2503529065","title":"CalciMedica Announces Appointment of DR. Alan Glicklich to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2503529065","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503529065?lang=en_us&edition=fundamental","pubTime":"2025-01-14 20:00","pubTimestamp":1736856007,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nTUA7NR9WH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2503881521","title":"Press Release: CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2503881521","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503881521?lang=en_us&edition=fundamental","pubTime":"2025-01-14 20:00","pubTimestamp":1736856000,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., Jan. 14, 2025 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced the appointment of Alan Glicklich, M.D. to the Company's Board of Directors effective on January 15, 2025. Dr. Glicklich has more than 20 years of experience in the biotechnology industry and currently serves as Chief Medical Officer of Nuvig Therapeutics.\"I am impressed by the data from the multiple Phase 2 clinical trials with CalciMedica's drug, Auxora, which has shown a variety of benefits, including a substantial reduction in organ failure, in acute inflammatory diseases. These benefits are important to patients in CalciMedica's lead indications of acute pancreatitis and acute kidney injury, in which organ failure is a significant cause of mortality and morbidity, no dis","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","AP","03160","BK4099","TM","BK4585","BK4007","BK4588","BK4555","CALC"],"gpt_icon":0},{"id":"2485175596","title":"CalciMedica Announces Presentations at Upcoming Medical Meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2485175596","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485175596?lang=en_us&edition=fundamental","pubTime":"2024-11-21 05:05","pubTimestamp":1732136700,"startTime":"0","endTime":"0","summary":"Prof. Robert Sutton todeliver plenary presentation on Phase 2b CARPO trial of Auxora in Acute Pancreatitis at American Pancreatic Association  2024 Annual Meeting. Poster presentation on Phase 2b CARPO trial at Emergencies in Medicine  2024 Meeting. LA JOLLA, Calif., Nov. 20, 2024 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced the acceptance of an abstract for plenary presentation at the American Pancreatic Association  2024 Annual Meeting being held December 9-10 in Maui, HI, and the acceptance of an abstract for poster presentation at the Emergencies in Medicine  2024 Meeting being held December 8-13 in Maui, HI.Presentation Title: Auxora Decreases the Development of Severe Organ Failure in Patients with Acute Pancreatitis and SIRS. Presenter:Prof. Robert Sutton, B.A. , M.B., B.S., D.P","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-announces-presentations-upcoming-medical-210500876.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-announces-presentations-upcoming-medical-210500876.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","EIM","APA","BK4006","CALC","BK4213","BK4588","AP","BK4007"],"gpt_icon":0},{"id":"2483382292","title":"CalciMedica Price Target Maintained With a $16.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2483382292","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483382292?lang=en_us&edition=fundamental","pubTime":"2024-11-14 18:45","pubTimestamp":1731581100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CALC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 14, 2024 05:45 ET (10:45 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC"],"gpt_icon":0},{"id":"2483318838","title":"CalciMedica’s Financial Strength and Clinical Advancements Lead to Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2483318838","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483318838?lang=en_us&edition=fundamental","pubTime":"2024-11-13 23:35","pubTimestamp":1731512115,"startTime":"0","endTime":"0","summary":"Analyst Joseph Pantginis of H.C. Wainwright reiterated a Buy rating on CalciMedica (CALC – Research Report), retaining the price target of $16.00. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/calcimedicas-financial-strength-and-clinical-advancements-lead-to-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/calcimedicas-financial-strength-and-clinical-advancements-lead-to-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2483288636","title":"CalciMedica Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2483288636","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483288636?lang=en_us&edition=fundamental","pubTime":"2024-11-13 22:15","pubTimestamp":1731507355,"startTime":"0","endTime":"0","summary":"* CalciMedica Inc    reported a quarterly adjusted loss of 50 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -82 cents.  T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC"],"gpt_icon":0},{"id":"2483325000","title":"BRIEF-Calcimedica Reports Third Quarter 2024 Financial Results And Provides Clinical & Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2483325000","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483325000?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:23","pubTimestamp":1731504202,"startTime":"0","endTime":"0","summary":"Nov 13  - CalciMedica Inc   :   * CALCIMEDICA REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CLINICAL & CORPORATE UPDATES   * CALCIMEDICA INC: CASH POSITION IS EXPECTED TO FUND CURRENT OPERATIONS INTO FIRST HALF OF 2026Source text:   Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2483538009","title":"CalciMedica Q3 2024 GAAP EPS $(0.50), Inline, Proforma Cash, Cash Equivalents And Short-term Investments Of Approximately $23.7M, Which Is Expected To Fund Current Operations Into The First Half Of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2483538009","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483538009?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:16","pubTimestamp":1731500183,"startTime":"0","endTime":"0","summary":"CalciMedica (NASDAQ:CALC) reported quarterly losses of $(0.50) per share which met the analyst consensus estimate.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41935435/calcimedica-q3-2024-gaap-eps-0-50-inline-proforma-cash-cash-equivalents-and-short-term-investments-","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CalciMedica Q3 2024 GAAP EPS $(0.50), Inline, Proforma Cash, Cash Equivalents And Short-term Investments Of Approximately $23.7M, Which Is Expected To Fund Current Operations Into The First Half Of 2026","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC"],"gpt_icon":0},{"id":"2483005759","title":"CalciMedica Inc: Cash Position Is Expected to Fund Current Operations Into First Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2483005759","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483005759?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:00","pubTimestamp":1731499214,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUAB9HBV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2483005119","title":"CalciMedica Q3 Basic EPS USD -0.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2483005119","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483005119?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:00","pubTimestamp":1731499214,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nPLXC13565:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2483900948","title":"CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2483900948","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483900948?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:00","pubTimestamp":1731499200,"startTime":"0","endTime":"0","summary":"Additional positive data, including a win ratio analysis, announced from CARPO Phase 2b trial of Auxora in acute pancreatitis ; Company expects to be in a position to initiate Phase 3 program in 2025. Enrollment ongoing in Phase 2 KOURAGE trial in acute kidney injury  and in Phase 2 portion of CRSPA trial in asparaginase-induced pancreatic toxicity ; data from both trials expected in 2025. Following a public offering in October, the Company's cash position is expected to fund current operations into the first half of 2026. LA JOLLA, Calif., Nov. 13, 2024 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today reported financial results for the third quarter ended September 30, 2024 and provided clinical and corporate updates.Auxora demonstrated a statistically significant 100% relative risk reduction  in n","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-reports-third-quarter-2024-120000483.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-reports-third-quarter-2024-120000483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","AP","BK4006","CALC"],"gpt_icon":0},{"id":"2482821781","title":"PK AirFinance Arranges and Funds Scaled Portfolio Facility for CALC’s Sidecar Platform (CAG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2482821781","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482821781?lang=en_us&edition=fundamental","pubTime":"2024-11-11 21:00","pubTimestamp":1731330000,"startTime":"0","endTime":"0","summary":"NEW YORK, Nov. 11, 2024  -- PK AirFinance , a leading aviation lending platform and affiliate of Apollo , today announced the arrangement and funding of a $550 million loan facility with China Aircraft Leasing Group ’s sidecar platform – China Aircraft Global . The portfolio is secured by 21 narrowbody and 2 widebody aircraft. The collateral pool is diversified among 15 different airline operators located across the globe. PK is acting as sole lender, admin agent and security trustee on the secured loan facility.Gary Rothschild, CEO of PK AirFinance, commented, “PK is pleased to support CALC on this important transaction, which we believe demonstrates PK’s ability to structure and deliver scaled, fully underwritten financing solutions with speed of execution as the sole lender. We continue to see increasing demand for these type of bespoke, large-scale financing solutions, which we can tailor to customers’ specific needs and serve as a more flexible alternative to public markets.”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pk-airfinance-arranges-funds-scaled-130000843.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PK","IE00B3S45H60.SGD","BK4135","BK4007","BK4184","CALC","LU1571399168.USD","LU1791807156.HKD","APO","BK4218","BK4181","BK4585","BK4524","LU0006061336.USD","BK4588","LU1668664300.SGD","LU0106831901.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","BK4212","IE00B775SV38.USD","IE0002270589.USD","CAG","LU1323610961.USD"],"gpt_icon":0},{"id":"2481632902","title":"CalciMedica name Stephen Bardin as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2481632902","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481632902?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:16","pubTimestamp":1730985366,"startTime":"0","endTime":"0","summary":"CalciMedica (CALC) announced the appointment of Stephen Bardin as CFO and the planned departure of Daniel Geffken, Interim CFO upon filing the comp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-name-stephen-bardin-as-cfo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-name-stephen-bardin-as-cfo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2481034919","title":"BRIEF-CalciMedica Strengthens Leadership Team With Appointment Of Stephen Bardin As Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2481034919","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481034919?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:17","pubTimestamp":1730981852,"startTime":"0","endTime":"0","summary":"Nov 7  - CalciMedica Inc   :   * CALCIMEDICA STRENGTHENS LEADERSHIP TEAM WITH APPOINTMENT OF STEPHEN BARDIN AS CHIEF FINANCIAL OFFICER   * CALCIMEDICA INC - APPOINTS STEPHEN BARDIN AS CFO   * CALCIMEDICA INC - DANIEL GEFFKEN TO DEPART AS INTERIM CFOSource text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4120","BK4007","CALC","TISI"],"gpt_icon":0},{"id":"2481908712","title":"CalciMedica Inc - Appoints Stephen Bardin as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2481908712","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481908712?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:00","pubTimestamp":1730980834,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUABJRGZB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2481790850","title":"CalciMedica Strengthens Leadership Team With Appointment of Stephen Bardin as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2481790850","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481790850?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:00","pubTimestamp":1730980834,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUABJRGZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":55,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CALC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-27","symbol":"CALC","fiscalQuarterEnding":"2024/12","expectedEps":-0.48,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2024-11-13","symbol":"CALC","fiscalQuarterEnding":"2024/09","expectedEps":-0.61,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.5},{"market":"US","date":"2024-08-12","symbol":"CALC","fiscalQuarterEnding":"2024/06","expectedEps":-0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723435200000,"reportTimeType":"post","actualEps":-0.52},{"market":"US","date":"2024-05-13","symbol":"CALC","fiscalQuarterEnding":"2024/03","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"post","actualEps":-0.43},{"market":"US","date":"2024-03-28","symbol":"CALC","fiscalQuarterEnding":"2023/12","expectedEps":1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1711598400000,"reportTimeType":"pre","actualEps":-0.23}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CALC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CALC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1734494400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CALC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CALC","date":"2025-04-25","current":-1.500724,"percent":0.863636,"low":-4.525842,"twenty":-3.555775,"median":-2.72853,"eighty":-1.652383,"high":-0.644854,"avg":-2.618509,"sd":0.960529,"marketCap":20559923},"quantilePoints":[{"date":"2024-01-05","current":-0.71129,"twenty":-0.71129,"median":-0.71129,"eighty":-0.71129,"marketCap":20480891},{"date":"2024-01-12","current":-0.644854,"twenty":-0.706809,"median":-0.663373,"eighty":-0.661399,"marketCap":18567932},{"date":"2024-01-19","current":-0.842346,"twenty":-0.707705,"median":-0.673245,"eighty":-0.662978,"marketCap":24254510},{"date":"2024-01-26","current":-1.017241,"twenty":-1.012132,"median":-0.706809,"eighty":-0.663373,"marketCap":29290430},{"date":"2024-02-02","current":-2.31259,"twenty":-1.35801,"median":-0.893146,"eighty":-0.671271,"marketCap":66588713},{"date":"2024-02-09","current":-1.906022,"twenty":-2.088582,"median":-1.017241,"eighty":-0.673245,"marketCap":54881987},{"date":"2024-02-16","current":-1.682223,"twenty":-2.119115,"median":-1.116267,"eighty":-0.690619,"marketCap":48437918},{"date":"2024-02-23","current":-1.643058,"twenty":-2.095833,"median":-1.634666,"eighty":-0.702071,"marketCap":47310206},{"date":"2024-03-01","current":-1.633733,"twenty":-2.020905,"median":-1.643058,"eighty":-0.709498,"marketCap":47041703},{"date":"2024-03-08","current":-1.652383,"twenty":-1.962717,"median":-1.659843,"eighty":-0.789924,"marketCap":47578709},{"date":"2024-03-15","current":-1.626273,"twenty":-1.923926,"median":-1.652383,"eighty":-0.903305,"marketCap":46826901},{"date":"2024-03-22","current":-1.428584,"twenty":-1.903784,"median":-1.64026,"eighty":-0.984091,"marketCap":41134640},{"date":"2024-03-28","current":-1.309808,"twenty":-1.864992,"median":-1.631159,"eighty":-1.013409,"marketCap":45001081},{"date":"2024-04-05","current":-1.359825,"twenty":-1.759493,"median":-1.626273,"eighty":-1.046819,"marketCap":46719500},{"date":"2024-04-12","current":-1.378581,"twenty":-1.683991,"median":-1.551673,"eighty":-1.099979,"marketCap":47363907},{"date":"2024-04-19","current":-1.25354,"twenty":-1.680731,"median":-1.469614,"eighty":-1.115647,"marketCap":43067861},{"date":"2024-04-26","current":-1.653672,"twenty":-1.680731,"median":-1.452232,"eighty":-1.163031,"marketCap":56815208},{"date":"2024-05-03","current":-1.87562,"twenty":-1.717206,"median":-1.540483,"eighty":-1.238535,"marketCap":64440690},{"date":"2024-05-10","current":-1.766209,"twenty":-1.764959,"median":-1.622543,"eighty":-1.25479,"marketCap":60681649},{"date":"2024-05-17","current":-3.903797,"twenty":-1.803163,"median":-1.628585,"eighty":-1.259167,"marketCap":58318824},{"date":"2024-05-24","current":-3.709686,"twenty":-1.90453,"median":-1.64026,"eighty":-1.263536,"marketCap":55418993},{"date":"2024-05-31","current":-4.076341,"twenty":-2.061189,"median":-1.652383,"eighty":-1.269686,"marketCap":60896452},{"date":"2024-06-07","current":-3.763144,"twenty":-2.28275,"median":-1.667303,"eighty":-1.292545,"marketCap":56217609},{"date":"2024-06-14","current":-3.626433,"twenty":-2.775108,"median":-1.674763,"eighty":-1.30043,"marketCap":54175287},{"date":"2024-06-21","current":-3.741558,"twenty":-3.626433,"median":-1.678493,"eighty":-1.306682,"marketCap":55895138},{"date":"2024-06-28","current":-2.266521,"twenty":-3.626433,"median":-1.678493,"eighty":-1.308558,"marketCap":33859554},{"date":"2024-07-05","current":-3.0652,"twenty":-3.626433,"median":-1.678493,"eighty":-1.309808,"marketCap":45791016},{"date":"2024-07-12","current":-3.396184,"twenty":-3.511308,"median":-1.683696,"eighty":-1.342725,"marketCap":50735586},{"date":"2024-07-15","current":-3.518504,"twenty":-3.517065,"median":-1.685169,"eighty":-1.342739,"marketCap":52562927},{"date":"2024-08-02","current":-3.223823,"twenty":-3.515626,"median":-1.694429,"eighty":-1.342753,"marketCap":48160698},{"date":"2024-08-09","current":-3.346156,"twenty":-3.502674,"median":-1.717881,"eighty":-1.345855,"marketCap":49988225},{"date":"2024-08-16","current":-3.501123,"twenty":-3.583261,"median":-1.750157,"eighty":-1.351697,"marketCap":44075639},{"date":"2024-08-23","current":-3.569438,"twenty":-3.582315,"median":-1.766209,"eighty":-1.354811,"marketCap":44935652},{"date":"2024-08-30","current":-3.67191,"twenty":-3.613882,"median":-1.801693,"eighty":-1.356667,"marketCap":46225670},{"date":"2024-09-06","current":-4.397752,"twenty":-3.637946,"median":-1.869368,"eighty":-1.357299,"marketCap":55363303},{"date":"2024-09-13","current":-3.552359,"twenty":-3.65203,"median":-1.906022,"eighty":-1.362326,"marketCap":44720648},{"date":"2024-09-20","current":-3.53528,"twenty":-3.640824,"median":-2.030976,"eighty":-1.373579,"marketCap":44505645},{"date":"2024-09-27","current":-3.859775,"twenty":-3.700214,"median":-2.125233,"eighty":-1.378581,"marketCap":48590705},{"date":"2024-10-04","current":-3.740224,"twenty":-3.708962,"median":-2.289556,"eighty":-1.380457,"marketCap":47085683},{"date":"2024-10-11","current":-3.371069,"twenty":-3.708962,"median":-2.722888,"eighty":-1.392648,"marketCap":42438390},{"date":"2024-10-18","current":-3.381146,"twenty":-3.700214,"median":-2.935837,"eighty":-1.41484,"marketCap":42565242},{"date":"2024-10-25","current":-3.53528,"twenty":-3.675822,"median":-3.058004,"eighty":-1.429837,"marketCap":44505645},{"date":"2024-10-31","current":-4.098876,"twenty":-3.6768,"median":-3.0652,"eighty":-1.43485,"marketCap":51600748},{"date":"2024-11-08","current":-3.744979,"twenty":-3.72195,"median":-3.072551,"eighty":-1.469614,"marketCap":47145546},{"date":"2024-11-15","current":-3.340773,"twenty":-3.734279,"median":-3.223823,"eighty":-1.536753,"marketCap":45394425},{"date":"2024-11-22","current":-3.420079,"twenty":-3.72195,"median":-3.270562,"eighty":-1.540483,"marketCap":46472038},{"date":"2024-11-29","current":-3.423065,"twenty":-3.714694,"median":-3.298285,"eighty":-1.558387,"marketCap":46512613},{"date":"2024-12-06","current":-2.966657,"twenty":-3.710325,"median":-3.295449,"eighty":-1.607623,"marketCap":40310931},{"date":"2024-12-13","current":-2.768218,"twenty":-3.706791,"median":-3.249448,"eighty":-1.624781,"marketCap":37614548},{"date":"2024-12-20","current":-2.748374,"twenty":-3.682653,"median":-3.194715,"eighty":-1.626273,"marketCap":37344910},{"date":"2024-12-27","current":-2.986501,"twenty":-3.673866,"median":-3.079903,"eighty":-1.62766,"marketCap":40580570},{"date":"2025-01-03","current":-3.264315,"twenty":-3.665078,"median":-3.095642,"eighty":-1.630644,"marketCap":44355506},{"date":"2025-01-10","current":-2.976579,"twenty":-3.653123,"median":-3.165095,"eighty":-1.634479,"marketCap":40445751},{"date":"2025-01-17","current":-3.145251,"twenty":-3.645198,"median":-3.087772,"eighty":-1.638582,"marketCap":42737676},{"date":"2025-01-24","current":-2.867437,"twenty":-3.640824,"median":-3.065538,"eighty":-1.643058,"marketCap":38962740},{"date":"2025-01-31","current":-2.52017,"twenty":-3.640824,"median":-3.058004,"eighty":-1.652383,"marketCap":34244069},{"date":"2025-02-07","current":-2.688843,"twenty":-3.640824,"median":-3.04842,"eighty":-1.652383,"marketCap":36535995},{"date":"2025-02-14","current":-2.649155,"twenty":-3.63798,"median":-3.022334,"eighty":-1.653672,"marketCap":35996718},{"date":"2025-02-21","current":-2.420951,"twenty":-3.628742,"median":-2.996423,"eighty":-1.664577,"marketCap":32895877},{"date":"2025-02-28","current":-2.2622,"twenty":-3.626433,"median":-2.986501,"eighty":-1.670287,"marketCap":30738770},{"date":"2025-03-07","current":-2.182824,"twenty":-3.621826,"median":-2.966657,"eighty":-1.674017,"marketCap":29660217},{"date":"2025-03-14","current":-1.885166,"twenty":-3.613842,"median":-2.897203,"eighty":-1.674763,"marketCap":25615642},{"date":"2025-03-21","current":-2.083605,"twenty":-3.598472,"median":-2.84934,"eighty":-1.677747,"marketCap":28312025},{"date":"2025-03-28","current":-2.053839,"twenty":-3.588224,"median":-2.832711,"eighty":-1.678493,"marketCap":27907568},{"date":"2025-04-04","current":-1.800869,"twenty":-3.578114,"median":-2.788062,"eighty":-1.678493,"marketCap":24671908},{"date":"2025-04-11","current":-1.456441,"twenty":-3.570753,"median":-2.763257,"eighty":-1.678493,"marketCap":19953237},{"date":"2025-04-17","current":-1.515486,"twenty":-3.564314,"median":-2.743413,"eighty":-1.673271,"marketCap":20762152},{"date":"2025-04-25","current":-1.500724,"twenty":-3.555775,"median":-2.72853,"eighty":-1.652383,"marketCap":20559923}],"updateTime":1745709464568}}}